Dr. Rui Li, MD, PhD

Dr. Li practices at Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services.

Dr. Li's NPI, 1689871535, was assigned on July 2, 2007. Dr. Li holds Oregon license MD168043.

Dr. Li's primary practice is Providence Portland Medical Center, at 4805 NE Glisan Street, Portland, OR 97213 in Multnomah County. The practice phone is (503) 215-1111.

Dr. Li's primary practice is Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services. Dr. Li is also affiliated with OHSU Hospital. The medical group on file is Providence Medical Group, Oregon. Dmand AI also links Dr. Li to 3 more hospitals, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Li practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Li's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Li is licensed in Oregon.

CMS data shows 1,467 Medicare services from Dr. Li across 5 procedure codes in 2024, for 271 Medicare patients. Medicare paid $81,607 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 271 Medicare patients who saw Dr. Li in 2024. The largest group is 65 to 74, with 133 patients. 64% of them have high blood pressure, and 54% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Li's median patient age at 73, with 51% women.

In 2024, Dr. Li wrote 2,366 Medicare Part D claims for 257 patients. 75% of them were for generic drugs. CMS names the drug for 2,120 of them, across 50 drugs with 11 or more claims each, at $6,632,373 in total drug cost. In 2023, CMS named 1,611 claims across 41 drugs.

Dr. Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Li as offering telehealth.

Dmand AI links 11 papers to Dr. Li, published from 2011 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Cryopreservation, Spectrum Analysis, Raman and Apoptosis.

Dmand AI links Dr. Li to 10 clinical trials, 4 of them phase 2 studies. 10 are still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms and Carcinoma, Squamous Cell. Providence Health & Services sponsors the most, 10.

CMS Open Payments shows 5 general payments to Dr. Li from 4 drug and device companies from 2018 to 2025. Education make up the largest share, 88% of the total. Sanofi and Genzyme US Companies paid the most, $188.